American scientists have developed an injectable drug that blocks HIV from entering cells. They say the new drug potentially offers long-lasting protection with fewer side effects and could eventually replace drug ‘cocktail’ therapies.
The lockdown has impacted on South Africa’s ARV treatment programme, delaying the South African National Aids Council national strategy. Yet, Covid-19 has also brought with it innovations in treatment and prevention for HIV, TB and STIs.
LIMPOPO – The South African Human Rights Commission (SAHRC) will be monitoring the readiness of public health facilities in Moutse before the Department of Health begins the process of transferring HIV patients from the Ndlovu Care Group into public health facilities of their choice.
MPUMALANGA – A simple question never asked, miscommunication, no communication or a patient’s fear of speaking to a busy nurse are all small issues that can end up becoming life-threatening disasters.
The world’s most important HIV scientific conference is currently underway in Paris – yet mere days ago, one of the country’s iconic AIDS activists died after battling with tuberculosis and pneumonia, a reminder that we’re nowhere near out of the woods when it comes to the virus.
Balancing HIV treatment with a myriad of ‘lifestyle’ diseases such as diabetes and hypertension is tricky. Patients have to take lots of pills, some medicines interact badly and there are side effects. But this is the future in our clinics as HIV positive patients age and poor diet and lack of exercise take their toll.
HIV positive teenagers in the Northern Cape have started defaulting on their treatment because of the difficulties they encounter as they regularly have to miss school in order to fetch their medication.